Why the study?
Managing competitive athletes with arrhythmias and sudden cardiac arrest risk requires guidance on differentiating low-risk from high-risk conditions, individualized risk assessment, shared decision-making, electrocardiogram interpretation, and tailored return-to-play protocols.
Provides updated clinical recommendations and return-to-play protocols for managing competitive athletes with arrhythmias and risks of sudden cardiac arrest through individualized risk assessment and shared decision-making.
Answers are grounded in this paper and cite their sources.
Clinicians should adopt individualized risk assessment for return-to-play decisions in athletes with arrhythmias; extends prior consensus with sport-specific pathways.
This document outlines recommendations for managing competitive athletes with arrhythmias and risks of sudden cardiac arrest, emphasizing individualized risk assessment, shared decision-making, and return-to-play protocols tailored to each athlete’s cardiac profile and sport demands. It provides evaluation strategies for ventricular arrhythmias, implantable cardiac defibrillators, atrial fibrillation, supraventricular tachycardia, Wolff–Parkinson–White pattern/syndrome, and syncope, alongside guidance for electrocardiogram interpretation in athletes. A key focus is placed on differentiating between low-risk and high-risk conditions, with recommendations for treatment strategies and ongoing monitoring to ensure athletes’ safety.
No takes yet. Share an insight, caveat, or question.
Darden et al. (2026) studied Arrhythmias and sudden cardiac arrest in competitive athletes. Individualized risk assessment, shared decision-making, and return-to-play protocols was evaluated. Task Force 8 recommendations emphasize individualized risk assessment, shared decision-making, and tailored return-to-play protocols for competitive athletes with arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: